Stemline Therapeutics (STML)

[$$$eeker]

$STML $22.66 Bought a small position @ $21.39, appears to have bottomed.

Balance Sheet
Total Cash (mrq): 87.67M
Total Cash Per Share (mrq): 6.93
Total Debt (mrq): 0.00
Total Debt/Equity (mrq): N/A
Current Ratio (mrq): 31.09
Book Value Per Share (mrq): 6.81

Share Statistics
Avg Vol (3 month)3: 219,929
Avg Vol (10 day)3: 201,762
Shares Outstanding5: 12.66M
Float: 9.62M
% Held by Insiders1: 9.68%
% Held by Institutions1: 11.20%
Shares Short (as of Jan 15, 2014)3: 424.19K
Short Ratio (as of Jan 15, 2014)3: 3.00
Short % of Float (as of Jan 15, 2014)3: 7.50%

Recommendation Summary*
Mean Recommendation (this week): 2.3
Mean Recommendation (last week): 2.3
Change: 0.0
* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target: 33.75
Median Target: 38.00
High Target: 50.00
Low Target: 9.00
No. of Brokers: 4
Data provided by Thomson/First Call

Upgrades & Downgrades History
Date Research Firm Action From To
Aug 29, 2013 Jefferies Initiated Buy
Jul 29, 2013 Roth Capital Initiated Buy
Jun 18, 2013 Ladenburg Thalmann Initiated Buy
Mar 18, 2013 Aegis Capital Initiated Buy
Feb 12, 2013 WBB Securities Initiated Sell

http://yhoo.it/MxG6K9

NEW YORK, Feb. 4, 2014 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (STML) announced today that Ivan Bergstein, M.D., Stemline's CEO, will present at the 16th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference on Tuesday, February 11, 2014 at 11:30 AM ET. The conference will be held at the Waldorf Astoria in New York on February 10-11, 2014. A live webcast of the presentation can be viewed on the Company's website at www.stemline.com.

NEW YORK, Feb. 6, 2014 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (STML) announced today that Ivan Bergstein, M.D., Stemline's CEO, will present at the Leerink Global Healthcare Conference on Thursday, February 13, 2014 at 3:30 PM ET. The conference will be held at the Waldorf Astoria in New York City. A live webcast of the presentation can be viewed on the Company's website at www.stemline.com.